REFRACTORY PLASMABLASTIC LYMPHOMA

Clinical trials for REFRACTORY PLASMABLASTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY PLASMABLASTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY PLASMABLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Terminated 1

Targeted drug tested for aggressive lymphomas that Won't quit

Disease control Terminated

This study tested an experimental drug called belantamab mafodotin for people with two rare and aggressive types of lymphoma that had returned or not responded to prior treatments. The drug is designed to target and kill lymphoma cells directly. The goal was to see if the treatme…

Matched conditions: REFRACTORY PLASMABLASTIC LYMPHOMA

Phase: PHASE2 • Sponsor: Jacob Soumerai, MD • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

REFRACTORY PLASMABLASTIC LYMPHOMA

Get alerted when new REFRACTORY PLASMABLASTIC LYMPHOMA trials appear

Targeted drug tested for aggressive lymphomas that Won't quit